A precision medicine classification for treatment of acute myeloid leukemia in older patients
- Citation:
- J Hematol Oncol vol 14
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Accepted
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 10
- Parents:
- 2993
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, UG1CA189823, U10CA180882, U24CA196171, UG1CA233338, UG1CA233331, P50CA140158, U10CA180861, P30CA016058, R35 CA198183, U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Alice S. Mims Jessica Kohlschmidt Uma Borate James S. Blachly Shelley Orwick Ann-Kathrin Eisfeld Dimitrios Papaioannou Deedra Nicolet Krzysztof Mrόzek Eytan Stein Bhavana Bhatnagar Richard M. Stone Jonathan E. Kolitz Eunice S. Wang Bayard L. Powell Amy Burd Ross L. Levine Brian J. Druker Clara D. Bloomfield John C. Byrd
- Networks:
- LAPS-MA036, LAPS-NY016, LAPS-NY158, LAPS-OH007, NC002, NORTHWELL, OH070
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-8321, CALGB-20202, CALGB-8461, CALGB-8721, CALGB-10502, CALGB-10801, CALGB-11001, CALGB-11002, CALGB-8821, CALGB-8921, CALGB-8923, CALGB-9420, CALGB-9720
- Phases:
- 1, 1/2, 2, 3, N/A
- Keywords:
- Acute myeloid leukemia, Mutation, Cytogenetics, Precision medicine, Outcome